iodine has been researched along with Carcinoma, Hepatocellular in 52 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of our study was to determine the iodine dose per unit of body weight (BW) or body surface area (BSA) that is minimally required to detect hypervascular hepatocellular carcinoma (HCC) on 80-kVp CT." | 9.22 | Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT. ( Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Noda, Y; Ono, H, 2016) |
| "The aim of this study was to compare the intraindividual effects of contrast material with two different iodine concentrations on the conspicuity of hepatocellular carcinoma (HCC) and vascular and hepatic contrast enhancement during multiphasic, 64-section multidetector row CT (MDCT) in patients with cirrhosis using two contrast medium injection techniques." | 9.15 | Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis. ( Barnhart, H; Catalano, C; De Filippis, G; Di Martino, M; Guerrisi, A; Guerrisi, I; Marin, D; Masciangelo, R; Nelson, RC; Passariello, R, 2011) |
| "This study aimed to evaluate the clinical impact of low tube voltage computed tomography (CT) during hepatic arteriography (CTHA) using low iodine contrast to detect hepatocellular carcinoma (HCC)." | 8.12 | Clinical impact of low tube voltage computed tomography during hepatic arteriography with low iodine to detect hepatocellular carcinoma before transarterial chemoembolization. ( Batsaikhan, B; Inoue, A; Nitta, N; Ota, S; Sonoda, A; Takahashi, H; Takaki, K; Uemura, R; Watanabe, Y, 2022) |
| "Normalized iodine concentration in the arterial phase from spectral CT reflects tumor-derived angiogenesis and is a potential predictive biomarker for early recurrence of hepatocellular carcinoma." | 8.02 | Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection. ( Fu, D; Huang, X; Jin, G; Li, W; Liu, L; Luo, N; Su, D; Xie, J, 2021) |
| "To investigate the potential value of volumetric iodine quantification using preoperative dual-energy computed tomography (DECT) for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC)." | 7.96 | Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography. ( Jeon, SK; Joo, I; Kim, TM; Lee, JM; Martin, S; Park, SJ; Schmidt, B; Yoon, JH, 2020) |
| "We assessed the value of iodine concentration (IC) as a perfusion-derived response marker for hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) in comparison with volume perfusion computed tomography (VPCT) parameters." | 7.91 | Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration. ( Blum, AC; Haberland, U; Hepp, T; Horger, M; Kaufmann, S; Ketelsen, D; Nikolaou, K; Sauter, AW; Schulze, M; Thaiss, WM, 2019) |
| "This retrospective study was aimed to evaluate the reduced iodine load on image quality and diagnostic performance in multiphasic hepatic CT using a novel monoenergetic reconstruction algorithm (nMERA) in assessment of local tumor progression after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC)." | 7.91 | Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium. ( Chiou, YY; Huang, SS; Lin, YM; Shen, SH; Wu, MH, 2019) |
| "To investigate the value of third-generation dual-source dual-energy computed tomography (DECT) iodine quantification to distinguish hepatic neuroendocrine tumor (NET) metastasis from hepatocellular carcinoma (HCC) in non-cirrhotic liver parenchyma." | 7.88 | Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. ( Albrecht, MH; Booz, C; D'Angelo, T; Hammerstingl, R; Kaltenbach, B; Lenga, L; Martin, SS; Pfeifer, S; Vogl, TJ; Wichmann, JL, 2018) |
| "We conducted a retrospective study to evaluate the safety and efficacy of transarterial chemoembolization (TACE) combined with computed tomography-guided 125iodine implantation (TACE-125iodine) in hepatocellular carcinoma (HCC) patients with type B portal vein tumor thrombus (PVTT)." | 7.85 | Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. ( Geng, X; Guo, CY; Hu, HT; Jiang, L; Li, HL; Luo, JP; Yao, QJ, 2017) |
| "To investigate the diagnostic accuracy of dual-energy multidetector computed tomography (MDCT) with iodine quantification compared to conventional enhancement measurements in distinguishing bland from neoplastic portal vein thrombosis in patients with hepatocellular carcinoma." | 7.83 | Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. ( Ascenti, G; D'Angelo, T; Mazziotti, S; Pergolizzi, S; Scribano, E; Silipigni, S; Sofia, C, 2016) |
| "To investigate the value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma (HCC) after transcatheter arterial chemoebolization (TACE)." | 7.81 | [Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment]. ( Li, C; Wang, S; Xing, G; Zhao, X; Zhou, C, 2015) |
| "True positive hepatocellular carcinoma (563 vs 521, p=0." | 5.72 | Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI. ( Jie, Z; Jinkui, C; Jun, Z; Liping, L; Qiong, L; Wen, S; Zhong, Z, 2022) |
| "A 62-year-old woman with hepatocellular carcinoma (HCC) and asthma presented with acute abdominal pain and a decreased hemoglobin level." | 5.42 | Clear visualization of extravasation on angiography using carbon dioxide in a case of hepatocellular carcinoma rupture with unclear visualization using iodine contrast agent. ( Abe, M; Hiasa, Y; Hirooka, M; Koizumi, Y; Mochizuki, T; Ochi, H; Tada, F; Tanaka, H; Tokumoto, Y; Watanabe, T, 2015) |
| "The objective of our study was to determine the iodine dose per unit of body weight (BW) or body surface area (BSA) that is minimally required to detect hypervascular hepatocellular carcinoma (HCC) on 80-kVp CT." | 5.22 | Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT. ( Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Noda, Y; Ono, H, 2016) |
| "To prospectively assess the effect of reduced iodine load to contrast enhancement, image quality, and detectability of hepatocellular carcinomas (HCCs) in hepatic CT with a combination of 80 kVp tube voltage setting and adaptive statistical iterative reconstruction (ASIR) technique in patients with chronic liver disease." | 5.20 | Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube-voltage and adaptive statistical iterative reconstruction. ( Bae, KT; Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Kondo, H; Miyoshi, TRT; Noda, Y; Tanahashi, Y; Watanabe, H, 2015) |
| "To evaluate two different iodine concentrations of contrast material for detecting hypervascular hepatocellular carcinomas (HCCs) in cirrhotic liver by multi-detector row helical CT (MDCT) when a fixed contrast material volume and injection rate is used." | 5.15 | Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study. ( Fujii, M; Kawasaki, R; Sofue, K; Sugimura, K; Tsurusaki, M, 2011) |
| "The aim of this study was to compare the intraindividual effects of contrast material with two different iodine concentrations on the conspicuity of hepatocellular carcinoma (HCC) and vascular and hepatic contrast enhancement during multiphasic, 64-section multidetector row CT (MDCT) in patients with cirrhosis using two contrast medium injection techniques." | 5.15 | Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis. ( Barnhart, H; Catalano, C; De Filippis, G; Di Martino, M; Guerrisi, A; Guerrisi, I; Marin, D; Masciangelo, R; Nelson, RC; Passariello, R, 2011) |
| "To investigate the effect of different iodine concentrations of contrast material on aortic and hepatic enhancement and the detectability of hypervascular hepatocellular carcinoma (HCC) with multi-detector row computed tomography (CT) and a uniphasic contrast material injection technique." | 5.10 | Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. ( Awai, K; Hori, S; Onishi, H; Takada, K, 2002) |
| "This study aimed to evaluate the clinical impact of low tube voltage computed tomography (CT) during hepatic arteriography (CTHA) using low iodine contrast to detect hepatocellular carcinoma (HCC)." | 4.12 | Clinical impact of low tube voltage computed tomography during hepatic arteriography with low iodine to detect hepatocellular carcinoma before transarterial chemoembolization. ( Batsaikhan, B; Inoue, A; Nitta, N; Ota, S; Sonoda, A; Takahashi, H; Takaki, K; Uemura, R; Watanabe, Y, 2022) |
| "Normalized iodine concentration in the arterial phase from spectral CT reflects tumor-derived angiogenesis and is a potential predictive biomarker for early recurrence of hepatocellular carcinoma." | 4.02 | Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection. ( Fu, D; Huang, X; Jin, G; Li, W; Liu, L; Luo, N; Su, D; Xie, J, 2021) |
| ", hepatocellular carcinoma, includes occlusion of the tumor blood supply by arterial infusion of embolic microspheres (beads) suspended in iodine-based contrast under fluoroscopic guidance." | 4.02 | Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization. ( Boffi, Q; Britton, H; de Ruiter, QMB; Donahue, DR; Kim, YS; Lewis, AL; Moonen, C; Negussie, AH; Pritchard, WF; Storm, G; Wood, BJ, 2021) |
| "After cTACE in patients with hepatocellular carcinoma (HCC), the presence of a viable tumor correlated with enhancement scores based on the density measurements of iodine depositions in different phases of the CT scan." | 3.96 | Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization. ( Buechter, M; Haubold, J; Li, Y; Ludwig, JM; Theysohn, JM; Umutlu, L; Wetter, A, 2020) |
| "To investigate the potential value of volumetric iodine quantification using preoperative dual-energy computed tomography (DECT) for predicting microvascular invasion (MVI) of hepatocellular carcinoma (HCC)." | 3.96 | Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography. ( Jeon, SK; Joo, I; Kim, TM; Lee, JM; Martin, S; Park, SJ; Schmidt, B; Yoon, JH, 2020) |
| "This retrospective study was aimed to evaluate the reduced iodine load on image quality and diagnostic performance in multiphasic hepatic CT using a novel monoenergetic reconstruction algorithm (nMERA) in assessment of local tumor progression after radiofrequency ablation (RFA) of hepatocellular carcinoma (HCC)." | 3.91 | Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium. ( Chiou, YY; Huang, SS; Lin, YM; Shen, SH; Wu, MH, 2019) |
| "We assessed the value of iodine concentration (IC) as a perfusion-derived response marker for hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) in comparison with volume perfusion computed tomography (VPCT) parameters." | 3.91 | Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration. ( Blum, AC; Haberland, U; Hepp, T; Horger, M; Kaufmann, S; Ketelsen, D; Nikolaou, K; Sauter, AW; Schulze, M; Thaiss, WM, 2019) |
| "MD-iodine images in DECT allow for a quantitative assessment of contrast enhancement and washout, with improved CNR in hepatocellular carcinoma in comparison to MRI." | 3.88 | Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC. ( Kambadakone, A; Parakh, A; Patino, M; Pfeiffer, D; Rummeny, EJ; Sahani, DV, 2018) |
| "To investigate the value of third-generation dual-source dual-energy computed tomography (DECT) iodine quantification to distinguish hepatic neuroendocrine tumor (NET) metastasis from hepatocellular carcinoma (HCC) in non-cirrhotic liver parenchyma." | 3.88 | Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT. ( Albrecht, MH; Booz, C; D'Angelo, T; Hammerstingl, R; Kaltenbach, B; Lenga, L; Martin, SS; Pfeifer, S; Vogl, TJ; Wichmann, JL, 2018) |
| "We conducted a retrospective study to evaluate the safety and efficacy of transarterial chemoembolization (TACE) combined with computed tomography-guided 125iodine implantation (TACE-125iodine) in hepatocellular carcinoma (HCC) patients with type B portal vein tumor thrombus (PVTT)." | 3.85 | Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus. ( Geng, X; Guo, CY; Hu, HT; Jiang, L; Li, HL; Luo, JP; Yao, QJ, 2017) |
| "To assess the value of iodine concentration (IC) in computed tomography data acquired with 80 kVp, as a surrogate for perfusion imaging in hepatocellular carcinoma (HCC) and lymphoma by comparing iodine related attenuation (IRA) with quantitative Volume Perfusion CT (VPCT)-parameters." | 3.83 | Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp. ( Haberland, U; Horger, M; Kaufmann, S; Nikolaou, K; Sauter, AW; Spira, D; Thaiss, WM; Thomas, C, 2016) |
| "To investigate the diagnostic accuracy of dual-energy multidetector computed tomography (MDCT) with iodine quantification compared to conventional enhancement measurements in distinguishing bland from neoplastic portal vein thrombosis in patients with hepatocellular carcinoma." | 3.83 | Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma. ( Ascenti, G; D'Angelo, T; Mazziotti, S; Pergolizzi, S; Scribano, E; Silipigni, S; Sofia, C, 2016) |
| "To investigate the value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma (HCC) after transcatheter arterial chemoebolization (TACE)." | 3.81 | [Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment]. ( Li, C; Wang, S; Xing, G; Zhao, X; Zhou, C, 2015) |
| "A significant proportion of human cholangiocarcinomas expresses membrane sodium iodide symporter, which may permit radioiodine therapy." | 3.74 | Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma. ( Bioulac-Sage, P; Boisgard, R; Bréchot, C; Calès, P; Clerc, J; Faivre, J; Guettier, C; Hervé, J; Liu, B; Roux, J; Samuel, D; Tavitian, B; Valogne, Y; Yilmaz, F, 2007) |
| "Administration of a higher iodine concentration in the contrast materials is advantageous for the detection of both hyper- and hypo-vascular hepatocellular carcinomas (HCCs)." | 3.73 | Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients. ( Fukuda, K; Naruo, K; Tozaki, M, 2005) |
| "We enrolled participants at risk for hepatocellular carcinoma with decreased estimated glomerular filtration rates (< 60 mL/min/1." | 3.30 | Renal protection CT protocol using low-dose and low-concentration iodine contrast medium in at-risk patients of HCC and with chronic kidney disease: a randomized controlled non-inferiority trial. ( Kim, JH; Lee, ES; Lee, JM; Lee, SM; Park, JY; Yoon, JH, 2023) |
| "In contrast, among patients with hepatocellular carcinoma, mean contrast enhancement in lesions in the arterial phase was significantly superior in group A compared with group B." | 2.69 | Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. ( Balzer, J; Clauss, W; Felfe, R; Felix, R; Hänninen, EL; Pegios, W; Vogl, TJ, 2000) |
| "True positive hepatocellular carcinoma (563 vs 521, p=0." | 1.72 | Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI. ( Jie, Z; Jinkui, C; Jun, Z; Liping, L; Qiong, L; Wen, S; Zhong, Z, 2022) |
| "They were classified as hepatocellular carcinoma (HCC), regenerative or indeterminate, according to the European Association for the Study of the Liver criteria." | 1.62 | Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver: a retrospective study. ( Kumar, G; Kumar, S; Laroia, ST; Rastogi, A; Sarin, SK; Yadav, K, 2021) |
| "Diagnostic imaging of hepatocellular carcinoma (HCC) requires a liver CT or MRI multiphase acquisition protocol." | 1.51 | Spectral Photon-Counting Computed Tomography (SPCCT): in-vivo single-acquisition multi-phase liver imaging with a dual contrast agent protocol. ( Boussel, L; Coulon, P; Douek, P; Laugerette, A; Noël, PB; Pfeiffer, D; Rummeny, EJ; Si-Mohamed, S; Sigovan, M; Tatard-Leitman, V; Yagil, Y, 2019) |
| "• 40-keV images maximise conspicuity of hepatocellular carcinoma especially at hepatic-arterial phase." | 1.48 | Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol. ( Funama, Y; Hirata, K; Iyama, Y; Kidoh, M; Nagayama, Y; Nakagawa, M; Nakaura, T; Namimoto, T; Oda, S; Taguchi, N; Utsunomiya, D; Yamashita, Y; Yuki, H, 2018) |
| "A 62-year-old woman with hepatocellular carcinoma (HCC) and asthma presented with acute abdominal pain and a decreased hemoglobin level." | 1.42 | Clear visualization of extravasation on angiography using carbon dioxide in a case of hepatocellular carcinoma rupture with unclear visualization using iodine contrast agent. ( Abe, M; Hiasa, Y; Hirooka, M; Koizumi, Y; Mochizuki, T; Ochi, H; Tada, F; Tanaka, H; Tokumoto, Y; Watanabe, T, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (11.54) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (9.62) | 29.6817 |
| 2010's | 24 (46.15) | 24.3611 |
| 2020's | 17 (32.69) | 2.80 |
| Authors | Studies |
|---|---|
| Voss, BA | 1 |
| Khandelwal, A | 1 |
| Wells, ML | 1 |
| Inoue, A | 2 |
| Venkatesh, SK | 1 |
| Lee, YS | 1 |
| Johnson, MP | 1 |
| Fletcher, JG | 1 |
| Li, J | 1 |
| Zhao, S | 1 |
| Ling, Z | 1 |
| Li, D | 1 |
| Jia, G | 1 |
| Zhao, C | 1 |
| Lin, X | 2 |
| Dai, Y | 1 |
| Jiang, H | 1 |
| Wang, S | 2 |
| Qiong, L | 1 |
| Jie, Z | 1 |
| Zhong, Z | 1 |
| Wen, S | 1 |
| Jun, Z | 1 |
| Liping, L | 1 |
| Jinkui, C | 1 |
| Maciel, J | 1 |
| Cavaco, D | 1 |
| Silvestre, C | 1 |
| Simões Pereira, J | 1 |
| Vilar, H | 1 |
| Leite, V | 1 |
| Mikhail, AS | 1 |
| Pritchard, WF | 2 |
| Negussie, AH | 2 |
| Inkiyad, G | 1 |
| Long, DJ | 1 |
| Mauda-Havakuk, M | 1 |
| Wakim, PG | 1 |
| van der Sterren, W | 1 |
| Levy, EB | 1 |
| Lewis, AL | 2 |
| Karanian, JW | 1 |
| Wood, BJ | 2 |
| Uemura, R | 1 |
| Takaki, K | 1 |
| Sonoda, A | 1 |
| Ota, S | 1 |
| Nitta, N | 1 |
| Batsaikhan, B | 1 |
| Takahashi, H | 2 |
| Watanabe, Y | 1 |
| Mahmoudi, S | 1 |
| Bernatz, S | 1 |
| Althoff, FC | 1 |
| Koch, V | 1 |
| Grünewald, LD | 1 |
| Scholtz, JE | 1 |
| Walter, D | 1 |
| Zeuzem, S | 1 |
| Wild, PJ | 1 |
| Vogl, TJ | 3 |
| Kinzler, MN | 1 |
| Narita, K | 1 |
| Nakamura, Y | 1 |
| Higaki, T | 1 |
| Kondo, S | 1 |
| Honda, Y | 1 |
| Kawashita, I | 1 |
| Mitani, H | 1 |
| Fukumoto, W | 1 |
| Tani, C | 1 |
| Chosa, K | 1 |
| Tatsugami, F | 1 |
| Awai, K | 2 |
| Bhandari, A | 1 |
| Koppen, J | 1 |
| Wastney, T | 1 |
| Hacking, C | 1 |
| Graafen, D | 1 |
| Stoehr, F | 1 |
| Halfmann, MC | 1 |
| Emrich, T | 1 |
| Foerster, F | 1 |
| Yang, Y | 1 |
| Düber, C | 1 |
| Müller, L | 1 |
| Kloeckner, R | 1 |
| Yoon, JH | 2 |
| Park, JY | 1 |
| Lee, SM | 1 |
| Lee, ES | 1 |
| Kim, JH | 1 |
| Lee, JM | 2 |
| Haubold, J | 1 |
| Ludwig, JM | 1 |
| Li, Y | 1 |
| Buechter, M | 1 |
| Wetter, A | 1 |
| Umutlu, L | 1 |
| Theysohn, JM | 1 |
| Elbanna, KY | 1 |
| Mansoori, B | 1 |
| Mileto, A | 1 |
| Rogalla, P | 1 |
| S Guimarães, L | 1 |
| Kim, TM | 1 |
| Joo, I | 1 |
| Park, SJ | 1 |
| Jeon, SK | 1 |
| Schmidt, B | 1 |
| Martin, S | 1 |
| Luo, N | 1 |
| Li, W | 1 |
| Xie, J | 1 |
| Fu, D | 1 |
| Liu, L | 1 |
| Huang, X | 1 |
| Su, D | 1 |
| Jin, G | 1 |
| de Ruiter, QMB | 1 |
| Britton, H | 1 |
| Donahue, DR | 1 |
| Boffi, Q | 1 |
| Kim, YS | 1 |
| Moonen, C | 1 |
| Storm, G | 1 |
| Laroia, ST | 1 |
| Yadav, K | 1 |
| Kumar, S | 1 |
| Rastogi, A | 1 |
| Kumar, G | 1 |
| Sarin, SK | 1 |
| Hu, HT | 1 |
| Luo, JP | 1 |
| Li, HL | 1 |
| Guo, CY | 1 |
| Yao, QJ | 1 |
| Geng, X | 1 |
| Jiang, L | 1 |
| Osawa, M | 1 |
| Takano, T | 1 |
| Hanawa, A | 1 |
| Minami, Y | 1 |
| Miura, H | 1 |
| Nagayama, Y | 1 |
| Nakaura, T | 1 |
| Oda, S | 1 |
| Utsunomiya, D | 1 |
| Funama, Y | 1 |
| Iyama, Y | 1 |
| Taguchi, N | 1 |
| Namimoto, T | 1 |
| Yuki, H | 1 |
| Kidoh, M | 1 |
| Hirata, K | 1 |
| Nakagawa, M | 1 |
| Yamashita, Y | 1 |
| Mulé, S | 1 |
| Pigneur, F | 1 |
| Quelever, R | 1 |
| Tenenhaus, A | 1 |
| Baranes, L | 1 |
| Richard, P | 1 |
| Tacher, V | 1 |
| Herin, E | 1 |
| Pasquier, H | 1 |
| Ronot, M | 1 |
| Rahmouni, A | 1 |
| Vilgrain, V | 1 |
| Luciani, A | 1 |
| Bargellini, I | 1 |
| Crocetti, L | 1 |
| Turini, FM | 1 |
| Lorenzoni, G | 1 |
| Boni, G | 1 |
| Traino, AC | 1 |
| Caramella, D | 1 |
| Cioni, R | 1 |
| Pfeiffer, D | 2 |
| Parakh, A | 1 |
| Patino, M | 1 |
| Kambadakone, A | 1 |
| Rummeny, EJ | 2 |
| Sahani, DV | 2 |
| Kaltenbach, B | 1 |
| Wichmann, JL | 1 |
| Pfeifer, S | 1 |
| Albrecht, MH | 1 |
| Booz, C | 1 |
| Lenga, L | 1 |
| Hammerstingl, R | 1 |
| D'Angelo, T | 2 |
| Martin, SS | 1 |
| Thaiss, WM | 2 |
| Haberland, U | 2 |
| Kaufmann, S | 2 |
| Hepp, T | 1 |
| Schulze, M | 1 |
| Blum, AC | 1 |
| Ketelsen, D | 1 |
| Nikolaou, K | 2 |
| Horger, M | 2 |
| Sauter, AW | 2 |
| Si-Mohamed, S | 1 |
| Tatard-Leitman, V | 1 |
| Laugerette, A | 1 |
| Sigovan, M | 1 |
| Coulon, P | 1 |
| Yagil, Y | 1 |
| Douek, P | 1 |
| Boussel, L | 1 |
| Noël, PB | 1 |
| Lin, YM | 1 |
| Chiou, YY | 1 |
| Wu, MH | 1 |
| Huang, SS | 1 |
| Shen, SH | 1 |
| Fujiwara, N | 1 |
| Tateishi, R | 1 |
| Akahane, M | 1 |
| Taguri, M | 1 |
| Minami, T | 1 |
| Mikami, S | 1 |
| Sato, M | 1 |
| Uchino, K | 2 |
| Enooku, K | 1 |
| Kondo, Y | 1 |
| Asaoka, Y | 1 |
| Yamashiki, N | 1 |
| Goto, T | 1 |
| Shiina, S | 1 |
| Yoshida, H | 1 |
| Ohtomo, K | 1 |
| Koike, K | 1 |
| Okada, M | 2 |
| Hyodo, T | 2 |
| Hidaka, S | 1 |
| Kagawa, Y | 1 |
| Matsuki, M | 1 |
| Tsurusaki, M | 2 |
| Murakami, T | 2 |
| Rothe, JH | 1 |
| Rudolph, I | 1 |
| Rohwer, N | 1 |
| Kupitz, D | 1 |
| Gregor-Mamoudou, B | 1 |
| Derlin, T | 1 |
| Furth, C | 1 |
| Amthauer, H | 1 |
| Brenner, W | 1 |
| Buchert, R | 1 |
| Cramer, T | 1 |
| Apostolova, I | 1 |
| Noda, Y | 2 |
| Kanematsu, M | 2 |
| Goshima, S | 2 |
| Kondo, H | 1 |
| Watanabe, H | 1 |
| Kawada, H | 2 |
| Kawai, N | 2 |
| Tanahashi, Y | 1 |
| Miyoshi, TRT | 1 |
| Bae, KT | 2 |
| Ochi, H | 1 |
| Hirooka, M | 1 |
| Koizumi, Y | 1 |
| Tada, F | 1 |
| Watanabe, T | 1 |
| Tokumoto, Y | 1 |
| Tanaka, H | 1 |
| Mochizuki, T | 1 |
| Abe, M | 1 |
| Hiasa, Y | 1 |
| Xing, G | 1 |
| Li, C | 1 |
| Zhao, X | 1 |
| Zhou, C | 1 |
| Spira, D | 1 |
| Thomas, C | 1 |
| Ono, H | 1 |
| Ascenti, G | 1 |
| Sofia, C | 1 |
| Mazziotti, S | 1 |
| Silipigni, S | 1 |
| Pergolizzi, S | 1 |
| Scribano, E | 1 |
| Ma, X | 1 |
| Samir, AE | 1 |
| Holalkere, NS | 1 |
| Sofue, K | 1 |
| Kawasaki, R | 1 |
| Fujii, M | 1 |
| Sugimura, K | 1 |
| Guerrisi, A | 1 |
| Marin, D | 1 |
| Nelson, RC | 1 |
| De Filippis, G | 1 |
| Di Martino, M | 1 |
| Barnhart, H | 1 |
| Masciangelo, R | 1 |
| Guerrisi, I | 1 |
| Passariello, R | 1 |
| Catalano, C | 1 |
| Fujigai, T | 1 |
| Kumano, S | 1 |
| Imaoka, I | 1 |
| Yagyu, Y | 1 |
| Ashikaga, R | 1 |
| Ishii, K | 1 |
| Takumi, K | 1 |
| Fukukura, Y | 1 |
| Shindo, T | 1 |
| Kumagae, Y | 1 |
| Tateyama, A | 1 |
| Kamiyama, T | 1 |
| Nakajo, M | 1 |
| Yu, Y | 1 |
| Chen, K | 1 |
| Chai, W | 1 |
| Hu, S | 1 |
| Tang, R | 1 |
| Zhang, J | 1 |
| Cao, L | 1 |
| Yan, F | 1 |
| Takada, K | 1 |
| Onishi, H | 1 |
| Hori, S | 1 |
| Tozaki, M | 1 |
| Naruo, K | 1 |
| Fukuda, K | 1 |
| Liu, B | 1 |
| Hervé, J | 1 |
| Bioulac-Sage, P | 1 |
| Valogne, Y | 1 |
| Roux, J | 1 |
| Yilmaz, F | 1 |
| Boisgard, R | 1 |
| Guettier, C | 1 |
| Calès, P | 1 |
| Tavitian, B | 1 |
| Samuel, D | 1 |
| Clerc, J | 1 |
| Bréchot, C | 1 |
| Faivre, J | 1 |
| Hänninen, EL | 1 |
| Felfe, R | 1 |
| Pegios, W | 1 |
| Balzer, J | 1 |
| Clauss, W | 1 |
| Felix, R | 1 |
| Sorimachi, K | 1 |
| Robbins, J | 1 |
| Jemec, B | 1 |
| Bellabarba, D | 1 |
| Inada, M | 1 |
| Varsano-Aharon, N | 1 |
| Sterling, K | 1 |
| Berezovskiĭ, BS | 1 |
| Tanino, T | 1 |
| Tsumita, T | 1 |
| Ivashchenko, AT | 1 |
| Balmukhanov, BS | 1 |
| Toktamysova, ZS | 1 |
2 reviews available for iodine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
A systematic review and meta-analysis of spectral CT to differentiate focal liver lesions.
Topics: Angiomyolipoma; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Focal Nodular Hy | 2023 |
Dual-energy CT in diffuse liver disease: is there a role?
Topics: Carcinoma, Hepatocellular; Humans; Image Processing, Computer-Assisted; Iodine; Liver Neoplasms; Tom | 2020 |
9 trials available for iodine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Renal protection CT protocol using low-dose and low-concentration iodine contrast medium in at-risk patients of HCC and with chronic kidney disease: a randomized controlled non-inferiority trial.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Iodine; Liver Neoplasms; Radiation Dosage; Radiog | 2023 |
Can low-dose CT with iterative reconstruction reduce both the radiation dose and the amount of iodine contrast medium in a dynamic CT study of the liver?
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; L | 2014 |
Reducing iodine load in hepatic CT for patients with chronic liver disease with a combination of low-tube-voltage and adaptive statistical iterative reconstruction.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; End Stage Liver Disease; | 2015 |
Minimally Required Iodine Dose for the Detection of Hypervascular Hepatocellular Carcinoma on 80-kVp CT.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Body Weights and Measures; Carcinoma, Hepatocellular; C | 2016 |
Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver: comparison of different concentrations of contrast material with multi-detector row helical CT--a prospective randomized study.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Dose-Response Relationship, Drug | 2011 |
Effect of varying contrast material iodine concentration and injection technique on the conspicuity of hepatocellular carcinoma during 64-section MDCT of patients with cirrhosis.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cross-Over Studies; Humans; Inje | 2011 |
Optimal dose of contrast medium for depiction of hypervascular HCC on dynamic MDCT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dose-Response Relationship, Drug; Female; Hu | 2012 |
Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT.
Topics: Adult; Aged; Aged, 80 and over; Aortography; Carcinoma, Hepatocellular; Contrast Media; Female; Huma | 2002 |
Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Metho | 2000 |
41 other studies available for iodine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Impact of dual-energy 50-keV virtual monoenergetic images on radiologist confidence in detection of key imaging findings of small hepatocellular carcinomas using multiphase liver CT.
Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Iodine; Liver Neoplasms; Middle Aged; Radiography, | 2022 |
Dual-Energy Computed Tomography Imaging in Early-Stage Hepatocellular Carcinoma: A Preliminary Study.
Topics: Carcinoma, Hepatocellular; Humans; Iodine; Liver Neoplasms; Retrospective Studies; Tomography, X-Ray | 2022 |
Detection of hepatocellular carcinoma in a population at risk: iodine-enhanced multidetector CT and/or gadoxetic acid-enhanced 3.0 T MRI.
Topics: Carcinoma, Hepatocellular; Cohort Studies; Contrast Media; Gadolinium DTPA; Humans; Iodine; Liver Ne | 2022 |
Clinical outcomes of a cohort of 271 patients with lung metastases from differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Carcinoma, Hepatocellular; Female; Humans; Iodine; Iodine Radioisotopes; | 2022 |
Cone-Beam Computed Tomography-Based Spatial Prediction of Drug Dose After Transarterial Chemoembolization Using Radiopaque Drug-Eluting Beads in Woodchuck Hepatocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Con | 2022 |
Clinical impact of low tube voltage computed tomography during hepatic arteriography with low iodine to detect hepatocellular carcinoma before transarterial chemoembolization.
Topics: Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Humans; Iodi | 2022 |
Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; | 2022 |
Iodine maps derived from sparse-view kV-switching dual-energy CT equipped with a deep learning reconstruction for diagnosis of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Deep Learning; Humans; Iodine; Liver Neoplasms; Tomography, X-Ray Compute | 2023 |
Quantum iterative reconstruction on a photon-counting detector CT improves the quality of hepatocellular carcinoma imaging.
Topics: Algorithms; Carcinoma, Hepatocellular; Humans; Iodine; Liver Neoplasms; Tomography, X-Ray Computed | 2023 |
Measuring the density of iodine depositions: Detecting an invisible residual tumor after conventional transarterial chemoembolization.
Topics: Angiography; Arteries; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Et | 2020 |
Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Female; Humans; Iodine; Liver | 2020 |
Preoperative normalized iodine concentration derived from spectral CT is correlated with early recurrence of hepatocellular carcinoma after curative resection.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Iodine; Liver Neoplasms; Neoplasm Recurrence, Loc | 2021 |
Synthesis, characterization, and imaging of radiopaque bismuth beads for image-guided transarterial embolization.
Topics: Bismuth; Carcinoma, Hepatocellular; Contrast Media; Embolization, Therapeutic; Iodine; Liver Neoplas | 2021 |
Material decomposition using iodine quantification on spectral CT for characterising nodules in the cirrhotic liver: a retrospective study.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Humans; Iodine; Liver Cirrhosis; Liver Neopl | 2021 |
Transarterial chemoembolization combined with computed tomography-guided 125iodine implantation enhances survival in hepatocellular carcinoma patients with portal vein tumor thrombus.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Iodine; Liver Neoplasms; | 2017 |
Study of Hepatic Artery Cone-beam Imaging by Low-rate Injection in Iodinated Contrast Agent.
Topics: Aged; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media; Embolization, Therap | 2017 |
Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; Liver Diseases; Liver Neopl | 2018 |
Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; Iopamido | 2018 |
Response Assessment by Volumetric Iodine Uptake Measurement: Preliminary Experience in Patients with Intermediate-Advanced Hepatocellular Carcinoma Treated with Yttrium-90 Radioembolization.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Iodine; Ka | 2018 |
Iodine material density images in dual-energy CT: quantification of contrast uptake and washout in HCC.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iodine; L | 2018 |
Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Gastrointes | 2018 |
Dose Optimization of Perfusion-derived Response Assessment in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Comparison of Volume Perfusion CT and Iodine Concentration.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Comput | 2019 |
Spectral Photon-Counting Computed Tomography (SPCCT): in-vivo single-acquisition multi-phase liver imaging with a dual contrast agent protocol.
Topics: Abdomen; Absorptiometry, Photon; Animals; Carcinoma, Hepatocellular; Contrast Media; Disease Models, | 2019 |
Postablation assessment of hepatocellular carcinoma using dual-energy CT: Comparison of half versus standard iodine contrast medium.
Topics: Ablation Techniques; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Processi | 2019 |
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Injection | 2013 |
Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agents.
Topics: Animals; Carcinoma, Hepatocellular; Computer Simulation; Contrast Media; Image Interpretation, Compu | 2015 |
Clear visualization of extravasation on angiography using carbon dioxide in a case of hepatocellular carcinoma rupture with unclear visualization using iodine contrast agent.
Topics: Angiography; Carbon Dioxide; Carcinoma, Hepatocellular; Contrast Media; Extravasation of Diagnostic | 2015 |
[Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment].
Topics: Arteries; Carcinoma, Hepatocellular; Embolization, Therapeutic; Follow-Up Studies; Humans; Iodides; | 2015 |
Iodine concentration as a perfusion surrogate marker in oncology: Further elucidation of the underlying mechanisms using Volume Perfusion CT with 80 kVp.
Topics: Aged; Aged, 80 and over; Biomarkers; Blood Volume; Carcinoma, Hepatocellular; Cone-Beam Computed Tom | 2016 |
Dual-energy CT with iodine quantification in distinguishing between bland and neoplastic portal vein thrombosis in patients with hepatocellular carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Li | 2016 |
Optimal arterial phase imaging for detection of hypervascular hepatocellular carcinoma determined by continuous image capture on 16-MDCT.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Drug Administration Schedule; Fe | 2008 |
Feasibility of a fixed scan delay technique using a previous bolus tracking technique data for dynamic hepatic CT.
Topics: Algorithms; Carcinoma, Hepatocellular; Contrast Media; Feasibility Studies; Female; Humans; Iodine; | 2012 |
Hepatocellular carcinoma and focal nodular hyperplasia of the liver: differentiation with CT spectral imaging.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; | 2013 |
Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients.
Topics: Aged; Aged, 80 and over; Aorta, Abdominal; Carcinoma, Hepatocellular; Contrast Media; Female; Hepati | 2005 |
Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.
Topics: Animals; Autoradiography; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; | 2007 |
Metabolism of thyroid hormones by cultured monkey hepatocarcinoma cells. Nonphenolic ring dieodination and sulfation.
Topics: Carcinoma, Hepatocellular; Cell Line; Chromatography, Ion Exchange; Chromatography, Thin Layer; Hydr | 1977 |
Studies of the tumorigenic effect of two goitrogens.
Topics: Adenoma; Animals; Carcinoma, Hepatocellular; Diet; Glycolysis; Hyperplasia; Iodine; Liver Neoplasms; | 1977 |
Thyroxine transport and turnover in major nonthyroidal illness.
Topics: Adenocarcinoma; Adult; Aged; Biological Transport; Blood Proteins; Carcinoma; Carcinoma, Bronchogeni | 1968 |
[The state of the thyroid gland and tumor resistance of rats following administration of a minimal blastomogenic dose of strontium-90].
Topics: Animals; Carcinoma, Hepatocellular; Female; Iodine; Liver Neoplasms; Male; Neoplasm Transplantation; | 1969 |
Studies on the tumor-host relationship. IV. Tumor cell agglutination with survival mouse serum.
Topics: Agglutination; Animals; Calcium; Carbohydrates; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; | 1972 |
[Effect of monovalent ions on the glycolysis and respiration of ascitic tumor cells].
Topics: Animals; Ascites; Bromine; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Cell Line; Cesium; C | 1973 |